Renal dysfunction among HIV-infected patients starting antiretroviral therapy

AIDS

Volumn 25, Issue 11, 2011, Pages 1421-1425

  Msango, Leonard ^a,b,c   Downs, Jennifer A ^b,c   Kalluvya, Samuel E ^a,b   Kidenya, Benson R ^a   Kabangila, Rodrick ^a,b   Johnson, Warren D ^c   Fitzgerald, Daniel W ^c   Peck, Robert N ^a,b,c  

^a CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b Bugando Medical Centre   (Tanzania)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

antiretroviral therapy; HIV; renal dysfunction; sub Saharan Africa

Indexed keywords

ANTIRETROVIRUS AGENT; CREATININE;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SEX DIFFERENCE; TANZANIA;

ANTI-RETROVIRAL AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; RENAL INSUFFICIENCY; RISK FACTORS; TANZANIA;

EID: 79959984326     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328348a4b1     Document Type: Article

References (24)

1. Gardner LI, Holmberg SD, Williamson JM, Szczech LA, Carpenter CC, Rompalo AM, et al. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr 2003; 32:203-209. (Pubitemid 36222723)
2. Wyatt CM, Arons RR, Klotman PE, Klotman ME. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. AIDS 2006; 20:561-565. (Pubitemid 43731600)
3. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach 2010; http://www.who.int/hiv/pub/ arv/adult2010/en/index.html. [Accessed 8 April 2011].
4. Gupta SK, Eustace JA, Winston JA, Boydstun Il, Ahuja TS, Rodriguez RA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40:1559-1585. (Pubitemid 40720806)
5. Fine D. Renal disease and toxicities: issues for HIV care providers. Top HIV Med 2007; 14:164-169.
6. Estrella MM, Fine DM. Screening for chronic kidney disease in HIV-infected patients. Adv Chronic Kidney Dis 2010; 17:26-35.
7. Wyatt CM, Hoover DR, Shi Q, Seaberg E, Wei C, Tien PC, et al. Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection. J Acquir Immune Defic Syndr 2010; 55:73-77.
8. Stöhr W, Walker AS, Munderi P, Tugume S, Gilks CF, Darbyshire JH, et al. Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of the Cockroft-Gault and Modification of Diet in Renal Disease formulae. Antivir Ther 2008; 13:761-770.
9. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139:147-157.
10. Reid A, Stöhr W, Walker AS, Williams IG, Kityo C, Hughes P, et al. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis 2008; 46:1271-1281. (Pubitemid 351589914)
11. Wools-Kaloustian K, Gupta SK, Muloma E, Owino-Ong'or W, Sidle J, Aubrey RW, et al. Renal disease in an antiretroviralnäve HIV-infected outpatient population in western Kenya. Nephrol Dial Transplant 2007; 22:2208-2212. (Pubitemid 47248464)
12. Peters PJ, Moore DM, Mermin J, Brooks JT, Downing R, Were W, et al. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int 2008; 74:925-929.
13. Mulenga LB, Kruse G, Lakhi S, Cantrell RA, Reid SE, Zulu I, et al. Baseline renal insufficiency and risk of death among HIVinfected adults on antiretroviral therapy in Lusaka, Zambia. AIDS 2008; 22:1821-1827.
14. Fabian J, Naicker S. HIV and kidney disease in sub-Saharan Africa. Nat Rev Nephrol 2009; 5:591-598.
15. Han TM, Naicker S, Ramdial RK, Assounga AG. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 2006; 69:2243-2250. (Pubitemid 43882112)
16. Fabian J, Naicker S, Nenter WDF, Baker L, Pharma D, Naidoo S, et al. Urinary screening abnormalities in antiretroviral-näve HIV-infected outpatients and implications for management: a single-center study in South Africa. Ethn Dis (Suppl 1) 2009; 19:80-85.
17. Emem CP, Arogundde F, Sanusi A, Adelusola K, Wokoma F, Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transpl 2008; 23:741-746. (Pubitemid 351767653)
18. Gemtholtz TE, Goetsch SJ, Katz I. HIV-related nephropathy: a South African perspective. Kidney Int 2006; 69:1895-1991.
19. Harris M. Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients. Expert Opin Drug Saf 2008; 7:389-400.
20. Nelson MR, Katlama C, Montaner JS, Cooper DA, Gazzard B, Clotet B, et al. The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. AIDS 2007; 21:1273-1281. (Pubitemid 46883481)
21. Verhelst D, Monge M, Meynard JL, Fouqueray B, Mougenot B, Girard PM, et al. Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am J Kidney Dis 2002; 40:1331-1333. (Pubitemid 35403147)
22. Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney Int 2010; 78:1171-1177.
23. Gilead Sciences, Incorporated. Viread full US prescribing information. Gilead products website. http://www.gilead.com/ pdf/viread-pi.pdf. [Accessed 12 July 2010].
24. GlaxoSmithKline. Epivir full US prescribing information. Glaxo-SmithKline US website. http://us.gsk.com/products/assets/us- epivir.pdf. [Accessed 12 July 2010].